Active immunotherapy for Alzheimer's disease
Lancet Neurol
.
2012 Jul;11(7):571-2.
doi: 10.1016/S1474-4422(12)70136-9.
Epub 2012 Jun 6.
Author
Thomas Wisniewski
1
Affiliation
1
New York University School of Medicine, Department of Neurology, Psychiatry, and Pathology, Alexandria East River Science Park, New York, NY 10016, USA.
[email protected]
PMID:
22677257
PMCID:
PMC3560289
DOI:
10.1016/S1474-4422(12)70136-9
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease / drug therapy*
Alzheimer Disease / immunology*
Amyloid beta-Peptides / immunology*
Female
Humans
Immunotherapy*
Male
Substances
Amyloid beta-Peptides
Grants and funding
P30 AG008051/AG/NIA NIH HHS/United States
R01 AG020245/AG/NIA NIH HHS/United States
R01 NS073502/NS/NINDS NIH HHS/United States